Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

Ekso Bionics Holdings (EKSO) Interest & Investment Income (2016)

Ekso Bionics Holdings (EKSO) has disclosed Interest & Investment Income for 5 consecutive years, with $20000.0 as the latest value for Q4 2017.

  • On a quarterly basis, Interest & Investment Income changed N/A to $20000.0 in Q4 2017 year-over-year; TTM through Sep 2016 was $27000.0, a 179.65% increase, with the full-year FY2016 number at $12000.0, up 9.09% from a year prior.
  • Interest & Investment Income was $20000.0 for Q4 2017 at Ekso Bionics Holdings, up from $8000.0 in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $47000.0 in Q4 2015 to a low of -$34000.0 in Q2 2016.
  • A 5-year average of $1375.0 and a median of $1332.0 in 2013 define the central range for Interest & Investment Income.
  • Biggest YoY gain for Interest & Investment Income was 2134.9% in 2015; the steepest drop was 1671.43% in 2015.
  • Ekso Bionics Holdings' Interest & Investment Income stood at $997.0 in 2013, then soared by 110.93% to $2103.0 in 2014, then soared by 2134.9% to $47000.0 in 2015, then tumbled by 82.98% to $8000.0 in 2016, then soared by 150.0% to $20000.0 in 2017.
  • Per Business Quant, the three most recent readings for EKSO's Interest & Investment Income are $20000.0 (Q4 2017), $8000.0 (Q3 2016), and -$34000.0 (Q2 2016).